These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25532779)

  • 1. Assessment of immunogenicity and protective efficacy of Microsporum canis secreted components coupled to monophosphoryl lipid-A adjuvant in a vaccine study using guinea pigs.
    Cambier L; Băguţ ET; Heinen MP; Tabart J; Antoine N; Mignon B
    Vet Microbiol; 2015 Feb; 175(2-4):304-11. PubMed ID: 25532779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental immunity to Microsporum canis and cross reactions with other dermatophytes of veterinary importance.
    Pier AC; Hodges AB; Lauze JM; Raisbeck M
    J Med Vet Mycol; 1995; 33(2):93-7. PubMed ID: 7658308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of immunogenicity and protective efficacy of a Microsporum canis metalloprotease subunit vaccine in guinea pigs.
    Vermout SM; Brouta FD; Descamps FF; Losson BJ; Mignon BR
    FEMS Immunol Med Microbiol; 2004 Jan; 40(1):75-80. PubMed ID: 14734190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant 31.5 kDa keratinase and a crude exo-antigen from Microsporum canis fail to protect against a homologous experimental infection in guinea pigs.
    Descamps FF; Brouta F; Vermout SM; Willame C; Losson BJ; Mignon BR
    Vet Dermatol; 2003 Dec; 14(6):305-12. PubMed ID: 14678442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, preparation, and evaluation of a novel non-adjuvanted polyvalent dermatophytes vaccine.
    Abo-Elyazeed H; Soliman R; Hassan H; El-Seedy FR; Aboul-Ella H
    Sci Rep; 2023 Jan; 13(1):157. PubMed ID: 36599863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity in guinea-pigs of a crude ribosomal fraction from Microsporum canis.
    Elad D; Segal E
    Vaccine; 1994 Feb; 12(2):134-8. PubMed ID: 8147094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
    Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
    BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunologic effects after inoculation of inactivated and combined live-inactivated dermatophytosis vaccines in cats.
    DeBoer DJ; Moriello KA; Blum JL; Volk LM; Bredahl LK
    Am J Vet Res; 2002 Nov; 63(11):1532-7. PubMed ID: 12428663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.
    Patil HP; Murugappan S; ter Veer W; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
    J Control Release; 2014 Jan; 174():51-62. PubMed ID: 24269505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hyaluronic acid-based combination adjuvant containing monophosphoryl lipid A and aluminum salt for hepatitis B vaccine.
    Moon SH; Shin EC; Noh YW; Lim YT
    Vaccine; 2015 Sep; 33(38):4762-9. PubMed ID: 26271830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the resistance to Microsporum canis on the basis of the guinea pig.
    Wawrzkiewicz K; Ziółkowska G; Wawrzkiewicz J
    Arch Vet Pol; 1994; 34(3-4):153-62. PubMed ID: 8891170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal ribosomal vaccines. II. Dermatophyte vaccine--initial studies on the antigenicity of a crude ribosomal fraction from Microsporum canis.
    Elad D; Segal E
    Mycopathologia; 1989 Jan; 105(1):49-51. PubMed ID: 2739692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations of a killed dermatophyte cell-wall vaccine against infection with Microsporum canis in cats.
    DeBoer DJ; Moriello KA
    Res Vet Sci; 1995 Sep; 59(2):110-3. PubMed ID: 8525097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB/c mice.
    Hu X; Liu R; Zhu N
    Immunobiology; 2013 Dec; 218(12):1524-8. PubMed ID: 23816301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine.
    Dong W; Bhide Y; Marsman S; Holtrop M; Meijerhof T; de Vries-Idema J; de Haan A; Huckriede A
    Biotechnol J; 2018 Apr; 13(4):e1700645. PubMed ID: 29278302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble
    Margaroni M; Agallou M; Athanasiou E; Kammona O; Kiparissides C; Gaitanaki C; Karagouni E
    Int J Nanomedicine; 2017; 12():6169-6184. PubMed ID: 28883727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New studies on the characterization of virulence factors in Microsporum canis].
    Mignon B
    Bull Mem Acad R Med Belg; 2005; 160(5-6):270-5. PubMed ID: 16465781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.
    Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A
    Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.
    Quintilio W; Kubrusly FS; Iourtov D; Miyaki C; Sakauchi MA; Lúcio F; Dias Sde C; Takata CS; Miyaji EN; Higashi HG; Leite LC; Raw I
    Vaccine; 2009 Jun; 27(31):4219-24. PubMed ID: 19393709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.